1741P Malignant effusion-derived non-small cell lung cancer organoid might be a feasible in vitro model for therapeutic screening

The feasibility of tumor-derived lung cancer organoid (LCO) for therapeutic screening has been documented. Studies demonstrating the feasibility of LCO established from malignant effusion are limited. In this study, we investigated the potential of effusion for establishing LCO and the potential of LCO for therapeutic screening.